Key result
Chronic thromboembolic disease diagnosed after acute pulmonary embolism requires a refined definition and further evaluation of optimal anticoagulation strategies.
Answers are grounded in this paper and cite their sources.
Highlights the need to refine the definition of chronic thromboembolic disease following acute pulmonary embolism and further evaluate optimal long-term anticoagulation strategies.
The recently updated European Society of Cardiology/European Respiratory Society guidelines for acute pulmonary embolism (PE) underline the importance of appropriate long-term management of PE sequelae in the era of extended anticoagulation [1]. Chronic thromboembolic disease (CTED) is one of several conditions contributing to breathlessness in this setting, i.e. persistent pulmonary vascular obstruction on imaging, with no evidence of pulmonary hypertension at rest. CTED is increasingly encountered in pulmonary vascular disease clinics following acute PE, and its diagnosis relies heavily on careful exclusion of other conditions that may contribute to symptoms. Chronic thromboembolic disease diagnosed following acute pulmonary embolism warrants refinement of its definition and further evaluation of optimal anticoagulation strategies http://bit.ly/38SQXc0
No takes yet. Share an insight, caveat, or question.
McCabe et al. (2020) conducted an editorial in Chronic thromboembolic disease (CTED) following acute pulmonary embolism. Extended anticoagulation was evaluated. Chronic thromboembolic disease diagnosed after acute pulmonary embolism requires a refined definition and further evaluation of optimal anticoagulation strategies.
Synapse has enriched 10 related papers. Consider them for comparative context: